News coverage about Humana (NYSE:HUM) has been trending somewhat positive recently, according to Accern. Accern identifies positive and negative media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Humana earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned press coverage about the insurance provider an impact score of 46.9737171834412 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

Humana (HUM) opened at $269.98 on Wednesday. The firm has a market capitalization of $36,928.31, a PE ratio of 22.94, a price-to-earnings-growth ratio of 1.46 and a beta of 0.95. Humana has a 12 month low of $203.48 and a 12 month high of $293.35. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.85 and a current ratio of 1.85.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.00 by $0.06. Humana had a return on equity of 16.13% and a net margin of 4.55%. The business had revenue of $13.19 billion during the quarter, compared to analysts’ expectations of $13.14 billion. During the same quarter in the previous year, the business posted $2.34 EPS. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. equities research analysts forecast that Humana will post 13.81 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, March 30th will be issued a $0.50 dividend. This is a positive change from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.74%. The ex-dividend date is Wednesday, March 28th. Humana’s payout ratio is 9.59%.

Humana announced that its board has authorized a stock buyback program on Thursday, December 14th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the insurance provider to purchase shares of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its shares are undervalued.

A number of research firms have recently weighed in on HUM. Zacks Investment Research downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday. JPMorgan Chase & Co. lifted their price objective on shares of Humana from $253.00 to $271.00 and gave the stock a “neutral” rating in a report on Monday, February 12th. Deutsche Bank boosted their price target on shares of Humana from $259.00 to $270.00 and gave the company a “hold” rating in a report on Friday, February 9th. Jefferies Group raised shares of Humana from a “hold” rating to a “buy” rating and set a $221.00 price target for the company in a report on Friday, January 12th. Finally, Cantor Fitzgerald reissued a “hold” rating and set a $230.00 price target on shares of Humana in a report on Tuesday, December 5th. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $270.47.

In other news, SVP Jody L. Bilney sold 7,054 shares of the company’s stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $247.89, for a total transaction of $1,748,616.06. Following the completion of the transaction, the senior vice president now directly owns 11,704 shares in the company, valued at $2,901,304.56. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Cynthia H. Zipperle sold 1,196 shares of the company’s stock in a transaction that occurred on Friday, March 9th. The stock was sold at an average price of $273.33, for a total value of $326,902.68. Following the transaction, the senior vice president now owns 7,771 shares of the company’s stock, valued at $2,124,047.43. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 41,775 shares of company stock valued at $11,169,845. Corporate insiders own 0.60% of the company’s stock.

WARNING: “Humana (HUM) Receives Media Sentiment Score of 0.21” was first posted by Marea Informative and is owned by of Marea Informative. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.mareainformativa.com/2018/03/14/humana-hum-earns-daily-news-impact-rating-of-0-21-updated-updated-updated.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Insider Buying and Selling by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.